10-Q · May 14, 2026
Jaguar Uranium Corp. reported no revenue for the first quarter of 2026, with a net loss of $19.87M compared to a net loss of $513K in the same period last year. Operating expenses increased significantly to $1.42M,…
Earnings analysis · 10-Q
JAGU earnings analysis
Filed August 12, 2026 · Our reading of the company's report
The latest report
Jaguar Uranium reported Q2 2026 EPS of negative $0.04, better than the negative $0.06 consensus estimate, but revenue remained $0.00 and the filing provides no gross margin, operating margin, segment, or free-cash-flow…
Read full summary
Jaguar Uranium reported Q2 2026 EPS of negative $0.04, better than the negative $0.06 consensus estimate, but revenue remained $0.00 and the filing provides no gross margin, operating margin, segment, or free-cash-flow detail. The company reported effective disclosure and internal controls as of June 30, 2026, with no material weaknesses, litigation, or previously unreported unregistered equity sales. Risk factors were unchanged from the December 31, 2025 Form 10-K, and no quantitative guidance was provided.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.04
What stood out
-
EPS Beat Consensus
Reported EPS was negative $0.04 for Q2 2026 versus negative $0.06 consensus, a $0.02 favorable variance, or 33.3% better than the estimate.
-
Disclosure Controls Effective
Management concluded that disclosure controls and procedures were effective as of June 30, 2026, providing reasonable assurance that required information was reported within SEC time periods.
-
No Material Control Weaknesses
Management concluded that internal control over financial reporting was effective as of June 30, 2026, and identified no material weaknesses.
-
No Material Litigation
The company reported no material litigation, arbitration, or governmental proceeding pending against the company or its management as of the filing.
-
No Unregistered Equity Sales
No unregistered sales of equity securities occurred during the three months ended June 30, 2026 that had not been previously reported.
What to watch
-
Existing Risks Remain Unchanged
The filing states that there were no material changes from the risk factors in the December 31, 2025 Form 10-K, so the previously disclosed exploration, financing, regulatory, and operating risks remain applicable.
-
No Revenue and Continuing Losses
The company reported revenue of $0.00 and EPS of negative $0.04 for Q2 2026, indicating continued dependence on external capital while it advances its uranium projects.
-
Inherent Control Limitations
The filing states that internal controls have inherent limitations and that future evaluations may be affected by changing conditions or deterioration in compliance, despite controls being effective as of June 30, 2026.
Management's outlook
The filing does not provide quantitative revenue or EPS guidance; no outlook, liquidity outlook, or capital-spending forecast was disclosed.
Earlier filings 2
10-K · March 27, 2026
Jaguar Uranium Corp. remains in the exploration stage with no operating revenues, having recorded a net loss of $2.31M in 2025, which is a reduction from $5.76M in 2024. The company raised $25M through its IPO in…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.